Topic

UnitedHealthcare (UnitedHealth Group)

A collection of 1139 issues

How to Get Zanzalintinib (XL092) Covered by UnitedHealthcare in Texas: Appeals, Compassionate Use, and Alternative Pathways

Answer Box: Getting Zanzalintinib (XL092) Covered in Texas Zanzalintinib (XL092) is investigational and typically denied by UnitedHealthcare outside clinical trials. Your fastest path: 1) Submit prior authorization with comprehensive medical necessity documentation through the UnitedHealthcare provider portal, 2) Request peer-to-peer review if denied, 3) File internal appeal within 180 days,
6 min read

Do You Qualify for Brensocatib (BRINSUPRI) Coverage by UnitedHealthcare in Texas? Decision Tree & Appeal Guide

Answer Box: To get Brensocatib (BRINSUPRI) covered by UnitedHealthcare in Texas, you need: (1) confirmed non-cystic fibrosis bronchiectasis diagnosis, (2) age 12+, (3) documented trial/failure of macrolide antibiotics, and (4) prior authorization through OptumRx. Submit PA via UnitedHealthcare Provider Portal with clinical notes showing ≥2 exacerbations in the past
6 min read

How to Get Emflaza (Deflazacort) Covered by UnitedHealthcare in Virginia: Complete Requirements Guide

Answer Box: Getting Emflaza Covered by UnitedHealthcare in Virginia Fast Track to Approval: UnitedHealthcare requires prior authorization for Emflaza (deflazacort) with step therapy—patients must try prednisone first unless contraindicated. Submit PA documentation including confirmed DMD diagnosis (ICD-10: G71.0), prednisone failure/intolerance records, and specialist notes through OptumRx. If
5 min read

Getting Nourianz (Istradefylline) Covered by UnitedHealthcare in Virginia: Complete Cost-Saving Guide with Appeals Templates

Answer Box: Getting Nourianz Covered by UnitedHealthcare in Virginia Nourianz (istradefylline) requires prior authorization from UnitedHealthcare and is typically placed on specialty tier (Tier 4/5) with higher copays. Virginia patients can reduce costs through Kyowa Kirin Cares copay assistance (commercial insurance only), tier exception requests, and Virginia's
7 min read

How Long Does It Take to Get Kalydeco (ivacaftor) Approved by UnitedHealthcare in New York? Complete Timeline & Appeals Guide

Answer Box: Getting Kalydeco Approved by UnitedHealthcare in New York Timeline: 3-14 days for initial decision. UnitedHealthcare must respond to Kalydeco prior authorization requests within 3 business days (non-urgent) or 24 hours (urgent) under New York state law. Most approvals happen within 5-7 days when complete documentation is submitted. Required:
6 min read

How Long Does It Take to Get Humate-P Approved by UnitedHealthcare in North Carolina? Complete Timeline & Approval Guide

Quick Answer: UnitedHealthcare typically processes Humate-P prior authorization requests within 7 calendar days in North Carolina, with expedited reviews in 2 business days for urgent cases. Success requires complete VWD subtype testing, documented desmopressin failure (when applicable), and proper clinical justification. Start by gathering lab results and having your provider
5 min read

How to Get Luxturna (Voretigene Neparvovec-Rzyl) Covered by UnitedHealthcare in Georgia: Complete Appeals Guide with Forms and Timelines

Quick Answer: Getting Luxturna Covered by UnitedHealthcare in Georgia Luxturna requires prior authorization from UnitedHealthcare with strict criteria: confirmed biallelic RPE65 mutations, viable retinal cells via OCT, and treatment at a Spark-designated center. If denied, you have 180 days for internal appeals, then 60 days for external review through Georgia&
7 min read

Renewing Ibrance (Palbociclib) Approval with UnitedHealthcare in New York: Timeline, Documents & Appeals

Answer Box: Renewing Ibrance Coverage with UnitedHealthcare in New York UnitedHealthcare requires annual prior authorization renewal for Ibrance (palbociclib), issued for 12-month periods. To renew successfully: (1) Submit reauthorization 30-60 days before expiration with documentation showing no disease progression, (2) Include required CBC monitoring results and any dose modifications, (3)
6 min read